In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of colorectal cancer (CRC) screening to the CMS Medicaid Adult Core Set of Quality Measures for adoption in 2022. However, CMS has the latitude to reject recommendations
from the Voting Members. The proposed CMS Medicaid CRC screening quality measure should be supported because it is actionable, has alignment with other metrics, is appropriate, is feasible, and will promote equity for all people insured through CMS.
Trending
- Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial (BMJ)
- Clinicians Encouraged to ‘See C. diff Differently’ as Diagnostics, Resistance Patterns, and Therapeutic Tools Shift (GI & Endoscopy News)
- AGA, ACG Express Concerns About New American Cancer Society Recommendations (GI & Endoscopy News)
- In vitro development of the Autonomous Colonoscope Robot System (ACRS) for fully automated colonoscope insertion (Nature)
- Zobair Younossi, MD, on Global Consensus Recommendations for MASLD/MASH (HMP Global Learning Network )
- Recommending Blood Tests for CRC Without Guardrails Risks Confusion (MedPage Today)
- Gut Microbiome Could Remain Disrupted For Over a Decade After Polyp Removal (ScienceAlert)
- Why physician is not the same as provider (KevinMD)
